Skip to main content
padlock icon - secure page this page is secure

Chemokines and Malaria Infection

Buy Article:

$68.00 + tax (Refund Policy)

Malaria is a devastating disease of the tropics, with an estimated 3.2 billion people exposed to the threat of malaria. There are 1-3 million deaths annually, mostly of children in sub-Saharan Africa. Deaths due to malaria often arise from complications of Plasmodium falciparum infection, particularly cerebral malaria, but difficulties during pregnancy also contribute to the high incidence of morbidity and mortality. Cytokines are known to play a major role in the pathogenesis of severe malaria, which is generally considered to be an immunopathological process. Chemokines are a family of chemotactic cytokines, with diverse roles that include cellular trafficking and neuronal signaling. Studies on chemokines in malaria infection indicate that they may be important mediators of the immune response to malaria. There is also evidence to suggest that chemokines are involved in the recruitment of leukocytes to the placenta during pregnancyassociated malaria, and also to the brain during cerebral malaria. Chemokines and infiltrating leukocytes can contribute to the severe manifestations of malaria through the actions of cytokines and other inflammatory mediators, for example, low birth weight in placental malaria, and neurological symptoms in cerebral malaria.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Chemokines; immunopathology; leukocytes; malaria

Document Type: Research Article

Publication date: November 1, 2006

More about this publication?
  • Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more